Cardiac Telemetry Articles & Analysis: Older
6 news found
The study titled “Near-Real Time Extended Ambulatory ECG Monitoring in Patients With Syncope Unveils a Spectrum of Arrhythmias and High Incidence of Atrial Fibrillation” utilized iRhythm’s proprietary database containing arrhythmia findings of patients prescribed Zio AT mobile cardiac telemetry for the diagnosis of syncope, or loss of ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux®, Biotricity’s ...
Bioflux-AI combines an FDA-approved, high-precision, small mobile cardiac telemetry (MCT) device with AI-driven algorithms specifically trained for the prediction of stroke in stage 4 and stage 5 CKD patients. ...
iRhythm Technologies has presented new data on its Zio wearable cardiac monitoring device at the American College of Cardiology (ACC) 71st Annual Scientific Session & Expo, building the clinical case for its devices. ...
Stratus offers technology, services, and proprietary software solutions to help neurologists accurately and quickly diagnose their patients with epilepsy and other seizure-like disorders. Stratus also provides mobile cardiac telemetry to support the diagnostic testing needs of the neurology ...
Located in the epicenter of the US coronavirus pandemic, Lenox Hill Hospital will be using Medicomp’s TelePatch™ mobile cardiac telemetry (MCT) monitor to measure the heart’s electrical conduction for abnormalities in patients that have been prescribed certain medications in the treatment of COVID-19. ...